JOHN OO: Open Payments
NPI 1396265864 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 65 payments from 19 companies in 2025. Trend: 2023 $1,215 · 2024 $1,527 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $183 |
| Medtronic, Inc. | 5 | $182 |
| AstraZeneca Pharmaceuticals LP | 5 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $148 |
| Paratek Pharmaceuticals, Inc. | 3 | $145 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Novo Nordisk Inc | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: Kerendia, NUZYRA, MINIMED 780G, BREZTRI, QULIPTA, INPEN SMART INSULIN DELIVERY SYSTEM, CREON, LEQVIO.
Industry payments across IN — which companies pay providers there.
